Top ▲
Target not currently curated in GtoImmuPdb
Target id: 1964
Nomenclature: cyclin dependent kinase 11B
Abbreviated Name: CDK11B
Family: PITSLRE subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 795 | 1p36.33 | CDK11B | cyclin dependent kinase 11B | |
Mouse | - | 784 | 4 86.73 cM | Cdk11b | cyclin dependent kinase 11B | |
Rat | - | 436 | 5q36 | Cdk11b | cyclin-dependent kinase 11B |
Database Links | |
Alphafold | P21127 (Hs), P24788 (Mm), P46892 (Rn) |
BRENDA | 2.7.11.22 |
ChEMBL Target | CHEMBL5808 (Hs) |
Ensembl Gene | ENSG00000248333 (Hs), ENSMUSG00000029062 (Mm), ENSRNOG00000017213 (Rn) |
Entrez Gene | 984 (Hs), 12537 (Mm), 252879 (Rn) |
Human Protein Atlas | ENSG00000248333 (Hs) |
KEGG Enzyme | 2.7.11.22 |
KEGG Gene | hsa:984 (Hs), mmu:12537 (Mm), rno:252879 (Rn) |
OMIM | 176873 (Hs) |
Pharos | P21127 (Hs) |
RefSeq Nucleotide | NM_033486 (Hs), NM_007661 (Mm), NM_145766 (Rn) |
RefSeq Protein | NP_277021 (Hs), NP_031687 (Mm), NP_665709 (Rn) |
UniProtKB | P21127 (Hs), P24788 (Mm), P46892 (Rn) |
Wikipedia | CDK11B (Hs) |
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: CDC2L1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
PITSLRE subfamily: cyclin dependent kinase 11B. Last modified on 19/12/2013. Accessed on 06/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=1964.